Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aerang Kim, M.D.
Children's National Hospital - Washington, DC
Principal Investigator - Alok Kothari, M.D.
Phoenix Children's Hospital
Principal Investigator - Javier Oesterheld, M.D.
Atrium Health Levine Children's Hospital - Carolinas Medical Center
Principal Investigator - Kieuhoa Vo, M.D.
UCSF - Mission Bay, Benioff Children's Hospital
Principal Investigator - Kyle Jackson, M.D.
Indiana University School of Medicine, Riley Hospital for Children
Principal Investigator - Lars Wagner, M.D.
Children's Hospital Medical Center, Cincinnati
Principal Investigator - Meghann McManus, D.O.
Sarah Cannon Research Institute, Pediatric Hematology & Oncology
Principal Investigator - Mia Weiss, M.D.
Washington University School of Medicine
Principal Investigator - Michael Deel, M.D.
Children's Hospital Medical Center, Cincinnati
Principal Investigator - Patrick Thompson, M.D.
UNC Chapel Hill - North Carolina Cancer Hospital
Principal Investigator - William Thomas Cash, M.D.
Children's Healthcare of Atlanta - Arthur M. Blank Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Ucsf, Mission Bay - Benioff Children'S Hospital
San Francisco, California, United States
- Children'S National Research Institute - Children'S National Hospital
Washington D.C., District of Columbia, United States
- Children'S Healthcare of Atlanta - Arthur M. Blank Hospital
Atlanta, Georgia, United States
- Indiana University School of Medicine, Riley Hospital for Children
Indianapolis, Indiana, United States
- Washington University - St. Louis
St Louis, Missouri, United States
- University of North Carolina at Chapel Hill - North Carolina Cancer Hospital
Chapel Hill, North Carolina, United States
- Atrium Health Levine Children'S Hospital - Carolinas Medical Center
Charlotte, North Carolina, United States
- Duke University Children'S Hospital and Health Center
Durham, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Sarah Cannon Research Institute, Pediatric Hematology & Oncology
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Oct 2021
- Primary completion
- 30 Jun 2026
- Completion
- 30 Jun 2026
- Last update posted
- 11 May 2026
- Registered enrollment
- 20
- Registry id
- NCT04337177
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.